期刊文献+

从循证医学的发展谈中医药人才的培养 被引量:2

A talk on cultivation of Chinese medicine professionals from aspect of EBM development
原文传递
导出
摘要 循证医学(EBM)核心内容是有关医疗的各项活动必须以客观的研究成果为依据,要求临床实践应以科学证据为指导,进行科学治病和客观研究,是医学治疗学的决策指南和发展方向,是世界医学界普遍适用的。中医药学重视对临床经验的积累和总结,以及对医学文献的收集和整理。传统中医药人才的培养模式是在中医的学术框架下发展起来的。随着循证医学的发展,中医药人才应当是具有较高的科研素质,能写出高水平的研究论文,是经验丰富的病史采集者、临床体检者、考虑周详的诊断者和治疗者。同时对中医药学生的创新能力和创造力的培养尤为重要。 The core of EBM is concerned with impersonal research production which is the basis of every medical activity and the guidance of every clinical pract ice. Chinese medicine put great stress on the accumulation and summary of clinic al experience and the collection and coordination of medical literatures. The mo des for training traditional Chinese medicine professionals are formed on the ac ademic Chinese medicine frames. With the development of EBM, Chinese medicine pr ofessionals are required to have high level of scientific research qualities to produce high level research papers, rich collection of patients' disease histori es, and considerate diagnosis and treatment. In the meanwhile, cultivation of th e students' creativity and innovation ability should be more emphasized.
作者 朱虹 张宗明
机构地区 南京中医药大学
出处 《中医教育》 2004年第1期14-16,共3页 Education of Chinese Medicine
关键词 循证医学 发展 中医药人才 人才培养 证据医学 EBM Chinese medicine talents cultivation
  • 相关文献

参考文献4

二级参考文献10

  • 1Echt DS,Leibson PR,Mitchel LB,et al.Cardiac arrhythmia suppression trial.N Engl Med,1989;321:406.
  • 2GISSI investigators.Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction.
  • 3USUS-2 Collaborative group.Randomized trial of intravenous streptokinase,oral aspirin,both,or neither among 17187 cases of suspected acute myocardial infarction:ISIS-2 Lancet,1988;Ⅱ:349.
  • 4The TIMI Ⅲ A investigators.Early effects of tissue-type plasminogen activator added to convention therapy on the culprit coronary lesion in patients presenting with ischemic cardiac pain at rest.Results of the thrombolysis in myocardial ischemia(TIMI II A) trial. Circulation, 1993;87:38.
  • 5The TIMI ⅢB investigators.Effects of tissue plasminogen.activator and a comparison of early invasive and conservative strategies in umtable angina and non-Q wave myocardial infarction.Results of the TIMI ⅢB trial Circulation, 1994;89:1545.
  • 6The Scandinavian Simvastatin Survival Study Guoup.Randomized trial of cholesterol lowering in 4444 patients with coronary heart disesse:the Scandinavian Simvastatin Survival Study(4S).Lancet,1994;344:1383.
  • 7Sacks FM, Pfeffer MA, Moye LA,et al.The effect of pravastatin on coronary events after myocardial irfarction in patients with average cholesterol levels.N Engl J Med,1996;335:1001.
  • 8The LIPID Study group. Design features and baseline characteristics of the LIPID Study:a randomized trial in Patients with previous acute myocardial infarction and/or unstable angina pectoris.Am J Cardiol, 1995;76:474.
  • 9Amiodarone Trial Meta-Analysis Investigators.Effect of prophylactic amiodarone on motality after acute myocardial infarction and in congestive heart failure:meta-analysis of individual data from 6500 patients in randomized trials.Lancet,1997;35):1417.
  • 10Chinese Cardiac Study Collaborative Group.Oral captopil versus placebo among 13 634 patients with suspected acute myocardial infarction:interim report from the Chinese Cardiac Study(CCS-1).Iancet,1995;345:686.

共引文献249

同被引文献22

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部